AIAI

Intangible assets: AIAI holds an exclusive field‑of‑use license to the M42 AI platform, but this advantage is related‑party, unproven at scale, and terminable for cause. The license also requires issuing ~25.1 million shares to M42 and paying an ongoing 3% revenue services fee, which weakens economic durability.

Constellation’s Dor analytics and network carry some IP and data assets, but revenue is modest and partially tied to volatile token rewards. Switching costs: modest for construction services; moderate for Dor subscriptions and certain healthcare navigation relationships, but not yet broad.

Network effects: potential within Constellation’s ecosystem is early and revenue‑light. Cost advantages: limited; CCCI may benefit from local vendor relationships and bonding capacity, yet construction remains competitive. Efficient scale: regional construction markets can reflect efficient scale, but cyclicality and bid dynamics cap pricing power.

Overall, multiple weak moats rather than one strong, durable moat.

CCCI’s revenue is mainly project‑based in competitive bidding environments with thin gross margins typical of civil construction, limiting sustainable price increases. Constellation’s Dor subscriptions have some pricing flexibility if value proves out, but the segment is small and token‑linked revenues are not a foundation for pricing power.

The perpetual 3% revenue fee to M42 structurally taxes margins, reducing room for price‑led EBIT expansion at the consolidated level. We do not see latent, monopoly‑like pricing levers comparable to best‑in‑class tollbooths.

First half 2026 combined revenue was ~$117.2 million with a combined net loss of ~$44.7 million. Results mix project seasonality in construction with early‑stage revenue from healthcare and crypto‑adjacent operations at Constellation. Exposure to token rewards and digital‑asset pricing materially lowers forecastability.

The direct‑listing structure and recent acquisitions mean only limited consolidated operating history. We expect high variability in quarterly earnings and free cash flow until at least 4–8 quarters of integrated reporting are available.

Pro forma year‑end 2025 balance data indicate cash of roughly $32.9 million and limited short‑term debt at holdco prior to any new credit facility.

CCCI generated $18.1 million operating cash flow in 2025 with $4.2 million of capex (implying FCF of ~$13.9 million); Constellation posted ~$0.4 million operating cash flow and negative FCF ($1.9 million).

However, a perpetual 3% of consolidated revenue services fee and planned amortization ($130.6 million per year) reduce earnings quality and potential FCF conversion at the group level. We treat leverage as manageable today but see probable future capital needs if growth outstrips internal cash.

AIAI issued substantial equity for a related‑party technology license (25.1 million shares), plus shares for an M42 affiliate investment (16.3 million shares), alongside shares for acquired companies in a direct listing that did not raise primary capital.

The technology services agreement imposes a 3% revenue fee in perpetuity, an unusual top‑line burden that impairs operating leverage. We also note director turnover shortly after listing.

This structure prioritizes growth through share issuance and related‑party arrangements over per‑share value compounding, making discipline and transparency critical before considering long‑term ownership.

Founder John P. Rochon controls 50.1% of voting power via Class B super‑voting shares and chairs the board.

His track record includes significant deal experience but also a prior CEO role at JRjr33 Inc., which entered bankruptcy in 2018, and he controls M42, the company’s core technology licensor, concentrating influence and introducing potential conflicts. CEO Todd Furniss brings healthcare and operations background.

Given the governance concentration and related‑party dependence, we require sustained execution and clear shareholder‑friendly actions to upgrade this score.